Early outcomes of transurethral thulium laser vapoenucleation of prostate
Închide
Articolul precedent
Articolul urmator
64 0
SM ISO690:2012
PLEŞACOV, Alexei; VLADANOV, Ivan; COLȚA, Artur. Early outcomes of transurethral thulium laser vapoenucleation of prostate. In: MedEsperaInternational Medical Congress for Students and Young Doctors. 8, 24-26 septembrie 2020, Chişinău. Chisinau, Republic of Moldova: 2020, pp. 76-77. ISBN 978-9975-151-11-5.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
MedEspera
8, 2020
Congresul "International Medical Congress for Students and Young Doctors"
8th edition, Chişinău, Moldova, 24-26 septembrie 2020

Early outcomes of transurethral thulium laser vapoenucleation of prostate


Pag. 76-77

Pleşacov Alexei, Vladanov Ivan, Colța Artur
 
”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
Disponibil în IBN: 21 decembrie 2020


Rezumat

Introduction. Surgical treatment of large benign prostatic hyperplasia (BPH) remain an important problem in endourology. Open surgical procedures are still used to treat pacients with BPH. Surgical trauma and numerous contraindications make it useless in many pacients with comorbydities. A small number of endourologic procedures offer the posibility to treat large BPH. Thus, laser surgery seems to be a salvage treatment for pacients with contrindications for classical open surgery. Aim of the study. The efficiency assesment of transurethral Thulium YAG laser vapoenucleation of prostate (ThuVEP). Materials and methods.. 16 patients with average age of 71 years underwent surgical treatment of large BPH. All of them underwent ThuVEP. A 550 micron end fire laser fiber was used during vapoenucleation. 80W power setings were used in all of the pacients. The period of surveillance was of 6 months. Preoperative investigations: PSA, IPSS, QoL, TRUS-P with PVR and Qmax. Patients inclusion criteria: Prostate Volume ≥80cm3, IPSS ≥16 and PVR ≥ 50ml, PSA≤4ng / ml, QoL> 4. Results. Average duration of intervention: 76 min. The prostate volume decreased postoperative on average from 83,2 cm3 to 35,4 cm3, there was an increase of average Qmax from 8,2 to 19.3 ml/s, a decrease in mean IPSS from 21,3 to 7,1, and PVR diminished from 69,1 ml to 16,1 ml. The period of transitional macrohematuria was 2,1 days. The duration of cateterization was 2,5 and mean hemoglobin drop was 2,1 g/l. Conclusions. ThuVEP is an effective method for endourologic treatment of large BPH. Immediate postoperative results of ThuVEP are promising. It is to mention a high haemorrage safe features of ThuVEP.

Cuvinte-cheie
Thulium: YAG laser, vapoenucleation, prostate